Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merus N.V. - Common Shares (NQ:MRUS)

55.37 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 54.00 (2)
Ask (Size) 55.93 (1)
Prev. Close 55.37
Today's Range 55.37 - 55.37
52wk Range 33.19 - 61.28
Shares Outstanding 46,530,884
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Merus to Present at Upcoming Investor Conferences
From Merus N.V.
Via GlobeNewswire
D-Wave Quantum And Advance Auto Parts Are Among Top 7 Mid-Cap Gainers Last Week (May 19-May 23): Are The Others In Your Portfolio?
Top mid-cap stocks gained up to 53.47% in the last week, including QBTS, RGC, AAP, MRUS, OKLO, SBSW, and BGM. Are they in your portfolio? 
Via Benzinga

Performance

YTD
+30.9%
+30.9%
1 Month
+22.3%
+22.3%
3 Month
+18.4%
+18.4%
6 Month
+22.0%
+22.0%
1 Year
+0.9%
+0.9%

More News

Read More
Merus Stock Surges Over 35% On Strong Phase 2 Cancer Trial Results: What's Going On?
Via Benzinga
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
What's Going On With Merus Stock Monday?
Via Benzinga
Merus Stock Soars On Positive Phase 2 Drug Trial Data, Price Target Hikes: Retail’s Thrilled
Via Stocktwits
Frontline, Merus, Intuit And Other Big Stocks Moving Higher On Friday
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics
Via Investor's Business Daily
Discover the top movers in Friday's pre-market session.
Via Chartmill
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
From Merus N.V.
Via GlobeNewswire
Merus Announces the Journal Publication of Petosemtamab Mechanism of Action
From Merus N.V.
Via GlobeNewswire
Merus to Present at BofA Securities 2025 Health Care Conference
From Merus N.V.
Via GlobeNewswire
Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update
From Merus N.V.
Via GlobeNewswire
Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting
From Merus N.V.
Via GlobeNewswire
Merus to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
From Merus N.V.
Via GlobeNewswire
Merus Announces Financial Results for the Fourth Quarter and Full Year 2024 and Provides Business Update
From Merus N.V.
Via GlobeNewswire
Merus to Present at Upcoming Investor Conferences
From Merus N.V.
Via GlobeNewswire
Merus Shares Are Up Today: What's Going On?
Via Benzinga
Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
From Merus N.V.
Via GlobeNewswire
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Merus to Present at Citi's 2025 Virtual Oncology Leadership Summit
From Merus N.V.
Via GlobeNewswire
New England Journal of Medicine Publishes: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer
From Merus N.V.
Via GlobeNewswire
Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs
From Merus N.V.
Via GlobeNewswire
TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday
Via Benzinga

Frequently Asked Questions

Is Merus N.V. - Common Shares publicly traded?
Yes, Merus N.V. - Common Shares is publicly traded.
What exchange does Merus N.V. - Common Shares trade on?
Merus N.V. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Merus N.V. - Common Shares?
The ticker symbol for Merus N.V. - Common Shares is MRUS on the Nasdaq Stock Market
What is the current price of Merus N.V. - Common Shares?
The current price of Merus N.V. - Common Shares is 55.37
When was Merus N.V. - Common Shares last traded?
The last trade of Merus N.V. - Common Shares was at 05/29/25 04:00 PM ET
What is the market capitalization of Merus N.V. - Common Shares?
The market capitalization of Merus N.V. - Common Shares is 2.58B
How many shares of Merus N.V. - Common Shares are outstanding?
Merus N.V. - Common Shares has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.